Acorah Software Products - Accounts Production 19.2.350 false true 30 September 2024 1 October 2023 false 1 October 2024 30 September 2025 30 September 2025 03786960 J Lloyd-Jones iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 03786960 2024-09-30 03786960 2025-09-30 03786960 2024-10-01 2025-09-30 03786960 frs-core:CurrentFinancialInstruments 2025-09-30 03786960 frs-core:Non-currentFinancialInstruments 2025-09-30 03786960 frs-core:FurnitureFittings 2025-09-30 03786960 frs-core:FurnitureFittings 2024-10-01 2025-09-30 03786960 frs-core:FurnitureFittings 2024-09-30 03786960 frs-core:PlantMachinery 2025-09-30 03786960 frs-core:PlantMachinery 2024-10-01 2025-09-30 03786960 frs-core:PlantMachinery 2024-09-30 03786960 frs-core:ShareCapital 2025-09-30 03786960 frs-core:RetainedEarningsAccumulatedLosses 2024-10-01 2025-09-30 03786960 frs-core:RetainedEarningsAccumulatedLosses 2025-09-30 03786960 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 03786960 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 03786960 frs-bus:SmallEntities 2024-10-01 2025-09-30 03786960 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 03786960 frs-bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 03786960 frs-bus:Director1 2024-10-01 2025-09-30 03786960 frs-countries:EnglandWales 2024-10-01 2025-09-30 03786960 2023-09-30 03786960 2024-09-30 03786960 2023-10-01 2024-09-30 03786960 frs-core:CurrentFinancialInstruments 2024-09-30 03786960 frs-core:Non-currentFinancialInstruments 2024-09-30 03786960 frs-core:ShareCapital 2023-09-30 03786960 frs-core:ShareCapital 2024-09-30 03786960 frs-core:RetainedEarningsAccumulatedLosses 2023-10-01 2024-09-30 03786960 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2023-09-30 03786960 frs-core:RetainedEarningsAccumulatedLosses 2024-09-30
Registered number: 03786960
J L J Healthcare Limited
Financial Statements
For The Year Ended 30 September 2025
Oakensen (Bristol) Limited
Chartered Accountants
Westbury Court, Church Road
Westbury-on-Trym
Bristol
BS9 3EF
J L J Healthcare Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Statement of Changes in Equity | 3
Notes to the Financial Statements | 4—6

Page 1
J L J Healthcare Limited
Balance Sheet
As At 30 September 2025
Balance Sheet
Registered number: 03786960

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 548 |  | -
|  |  | 548 |  | -
CURRENT ASSETS
Stocks | 5 | 4,553 |  | 4,154 |
Debtors | 6 | 11,805 |  | 6,740 |
Cash at bank and in hand |  | 4,379 |  | 12,310 |
|  | 20,737 |  | 23,204 |
Creditors: Amounts Falling Due Within One Year | 7 | (5,179 ) |  | (6,984 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 15,558 |  | 16,220
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 16,106 |  | 16,220
Creditors: Amounts Falling Due After More Than One Year | 8 |  | (34,844 ) |  | (40,983 )
NET LIABILITIES |  |  | (18,738 ) |  | (24,763 )
CAPITAL AND RESERVES
Called up share capital | 9 |  | 100 |  | 100
Profit and Loss Account |  |  | (18,838 ) |  | (24,863 )
SHAREHOLDERS' FUNDS |  |  | (18,738) |  | (24,763)

Page 1
Page 2
J L J Healthcare Limited
Balance Sheet (continued)
As At 30 September 2025
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

J Lloyd-Jones Director
14 May 2026

The notes on pages 4 to 6 form part of these financial statements.
Page 2
Page 3
J L J Healthcare Limited
Statement of Changes in Equity
For The Year Ended 30 September 2025
Statement of Changes in Equity

| Share Capital | Profit and Loss Account | Total
--- | --- | --- | ---
| £ | £ | £
As at 1 October 2023 | 100 | (37,598 ) | (37,498)
Profit for the year and total comprehensive income | - | 12,735 | 12,735
As at 30 September 2024 and 1 October 2024 | 100 | (24,863 ) | (24,763)
Profit for the year and total comprehensive income | - | 6,025 | 6,025
As at 30 September 2025 | 100 | (18,838 ) | (18,738)

Page 3
Page 4
J L J Healthcare Limited
Notes to the Financial Statements
For The Year Ended 30 September 2025
Notes to the Financial Statements
1. General Information
J L J Healthcare Limited is a private company, limited by shares, incorporated in England & Wales, registered number 03786960 . The registered office is 24 Tenterfields Tenterfields, Halesowen, B63 3LH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery | 20% straight line.
Fixtures & Fittings | 20% straight line.

2.4. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Current tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current tax is also recognised in other comprehensive income or directly in equity respectively.
Page 4
Page 5
J L J Healthcare Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 September 2025
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2024: 3)
3 3
4. Tangible Assets

| Plant & Machinery | Fixtures & Fittings | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 October 2024 | - | - | -
Additions | 224 | 406 | 630
As at 30 September 2025 | 224 | 406 | 630
Depreciation
As at 1 October 2024 | - | - | -
Provided during the period | 41 | 41 | 82
As at 30 September 2025 | 41 | 41 | 82
Net Book Value
As at 30 September 2025 | 183 | 365 | 548
As at 1 October 2024 | - | - | -

5. Stocks

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Stock | 4,553 |  | 4,154

6. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 11,805 |  | 6,740

7. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Other creditors | 1,705 |  | 1,751
Taxation and social security | 3,474 |  | 5,233
| 5,179 |  | 6,984

Page 5
Page 6
J L J Healthcare Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 September 2025
8. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Other creditors | 34,844 |  | 40,983

9. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

Page 6